These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 3574818
1. Diethylstilbestrol-related clear-cell adenocarcinoma in women with initial examinations demonstrating no malignant disease. Kramer MS, Seltzer V, Krumholz B, Talebian F, Tedeschi C, Chen S. Obstet Gynecol; 1987 Jun; 69(6):868-71. PubMed ID: 3574818 [Abstract] [Full Text] [Related]
2. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma. Blythe JG, Michael H, Hodel KA. J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354 [Abstract] [Full Text] [Related]
4. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals. Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019 [Abstract] [Full Text] [Related]
5. Follow-up study of male and female offspring of DES-treated mothers a preliminary report. Bibbo M, Al-Naqeeb M, Baccarini I, Gill W, Newton M, Sleeper KM, Sonek RN, Wied GL. J Reprod Med; 1975 Jul; 15(1):29-32. PubMed ID: 1171234 [Abstract] [Full Text] [Related]
6. Management of the adolescent girl exposed in utero to DES. Gerbie MV. Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401 [Abstract] [Full Text] [Related]
7. The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females. Herbst AL, Scully RE, Robboy SJ. J Reprod Med; 1975 Jul; 15(1):5-11. PubMed ID: 1151941 [Abstract] [Full Text] [Related]
8. The current status of the DES-exposed population. Herbst AL. Obstet Gynecol Annu; 1981 Jul; 10():267-78. PubMed ID: 7024873 [Abstract] [Full Text] [Related]
9. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol. Scully RE, Robboy SJ, Herbst AL. Ann Clin Lab Sci; 1974 Jul; 4(4):222-33. PubMed ID: 4460850 [Abstract] [Full Text] [Related]
11. Clear-cell adenocarcinoma of the lower genital tract: Memorial Hospital 1974-1984. Jones WB, Koulos JP, Saigo PE, Lewis JL. Obstet Gynecol; 1987 Oct; 70(4):573-7. PubMed ID: 3627626 [Abstract] [Full Text] [Related]
12. Clear cell adenocarcinoma in young women. Kantor HI, Weinstein SA, Kaye HL. Obstet Gynecol; 1973 Mar; 41(3):443-6. PubMed ID: 4347264 [No Abstract] [Full Text] [Related]
13. Development of clear cell adenocarcinoma in DES-exposed offspring under observation. Kaufman RH, Korhonen MO, Strama T, Adam E, Kaplan A. Obstet Gynecol; 1982 Jun; 59(6 Suppl):68S-72S. PubMed ID: 7088431 [Abstract] [Full Text] [Related]
18. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina. Hill EC. Trans Pac Coast Obstet Gynecol Soc; 1972 Jun; 40():15-29. PubMed ID: 4668177 [No Abstract] [Full Text] [Related]
19. Genital clear cell adenocarcinoma. Johnston GA, Jones HA. Int Surg; 1983 Jun; 68(3):257-61. PubMed ID: 6662641 [Abstract] [Full Text] [Related]
20. The effects in the human of diethylstilbestrol (DES) use during pregnancy. Herbst AL. Princess Takamatsu Symp; 1987 Jun; 18():67-75. PubMed ID: 3506546 [Abstract] [Full Text] [Related] Page: [Next] [New Search]